Rules and Regulations. Notice
304 words·~1 min read·
/register/2003/03/04/03-4975·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee for Pharmaceutical Science; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration
(FDA)is announcing an amendment to the notice of meeting of the Advisory Committee for Pharmaceutical Science. This meeting was announced in the **Federal Register** of February 3, 2003 (68 FR 5297). The amendment is being made to reflect a change in the *Agenda* portion of the document. There are no other changes. FOR FURTHER INFORMATION CONTACT: Kathleen Reedy or LaNise Giles, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12539. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the **Federal Register** of February 3, 2003 (68 FR 5297), FDA announced that a meeting of the Advisory Committee for Pharmaceutical Science would be held on March 12 and 13, 2003. On page 5298, in the first column, the second sentence in the *Agenda* portion of the document is amended to read as follows: On March 13, 2003, the committee will:
(1)Discuss and provide direction for future subcommittee: Pharmacology/Toxicology Subcommittee;
(2)receive an update on the Office of Pharmaceutical Science research projects;
(3)discuss and provide comments on dose content uniformity, parametric interval test for aerosol products;
(4)discuss and provide comments on bioequivalence/bioavailability of endogenous drugs; and
(5)discuss and provide comments on comparability protocols. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: February 26, 2003. William K. Hubbard, Associate Commissioner for Policy and Planning. [FR Doc. 03-4975 Filed 3-3-03; 8:45 am]